Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination

被引：15
|
作者：
Golshani, Maryam [1 ]
Hrdy, Jiri [1 ]
机构：
[1] Charles Univ Prague, Fac Med, Inst Immunol & Microbiol, Prague 12800, Czech Republic
来源：
VACCINES | 2022年 / 10卷 / 02期
关键词：
SARS-CoV-2; COVID-19; multiple sclerosis; DMTs; immunosuppression; vaccine; EFFICACY;
D O I：
10.3390/vaccines10020279
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
This article reviews the literature on SARS-CoV-2 pandemic and multiple sclerosis (MS). The first part of the paper focuses on the current data on immunopathology of SARS-CoV-2 and leading vaccines produced against COVID-19 infection. In the second part of the article, we discuss the effect of Disease Modifying Therapies (DMTs) on COVID-19 infection severity or SARS-CoV-2 vaccination in MS patients plus safety profile of different vaccine platforms in MS patients.
引用
收藏
页数：18
相关论文
共 50 条
  • [1] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    Allman, M.
    Tallantyre, E.
    Robertson, N. P.
    [J]. JOURNAL OF NEUROLOGY, 2022, 269 (04) : 2259 - 2261
  • [2] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    M. Allman
    E. Tallantyre
    N. P. Robertson
    [J]. Journal of Neurology, 2022, 269 : 2259 - 2261
  • [3] The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying therapies
    Rabenstein, Monika
    Thomas, Olivia G.
    Carlin, Giorgia
    Khademi, Mohsen
    Hogelin, Klara Asplund
    Malmestrom, Clas
    Axelsson, Markus
    Brandt, Anne Frandsen
    Gafvelin, Guro
    Gronlund, Hans
    Kockum, Ingrid
    Piehl, Fredrik
    Lycke, Jan
    Olsson, Tomas
    Hessa, Tara
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3789 - 3798
  • [4] COVID-19 in patients with multiple sclerosis despite SARS-CoV-2 vaccination
    Mahadeen, A. Z.
    Rose, D.
    Carlson, A. K.
    Planchon, S. M.
    Sedlak, J.
    Cohen, J. A.
    Moss, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 794 - 795
  • [5] Effect of SARS-CoV-2 mRNA vaccination in multiple sclerosis patients treated with disease modifying therapies
    Sormani, M. P.
    Inglese, M.
    Schiavetti, I.
    Carmisciano, L.
    Laroni, A.
    Lapucci, C.
    Da Rin, G.
    Serrati, C.
    Gandoglia, I.
    Tassinari, T.
    Perego, G.
    Brichetto, G.
    Gazzola, P.
    Mannironi, A.
    Stromillo, M. L.
    Cordioli, C.
    Landi, D.
    Clerico, M.
    Signoriello, E.
    Frau, J.
    Ferro, M. T.
    Di Sapio, A.
    Pasquali, L.
    Ulivelli, M.
    Marinelli, F.
    Callari, G.
    Iodice, R.
    Liberatore, G.
    Caleri, F.
    Repice, A. M.
    Cordera, S.
    Battaglia, M. A.
    Salvetti, M.
    Franciotta, D.
    Uccelli, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 743 - 744
  • [6] SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
    Adamczyk-Sowa, Monika
    Mado, Hubert
    Kubicka-Baczyk, Katarzyna
    Jaroszewicz, Jerzy
    Sobala-Szczygiel, Barbara
    Bartman, Wojciech
    Sowa, Pawel
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 201
  • [7] Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
    Diego Centonze
    Maria A. Rocca
    Claudio Gasperini
    Ludwig Kappos
    Hans-Peter Hartung
    Melinda Magyari
    Celia Oreja-Guevara
    Maria Trojano
    Heinz Wiendl
    Massimo Filippi
    [J]. Journal of Neurology, 2021, 268 : 3961 - 3968
  • [8] Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
    Centonze, Diego
    Rocca, Maria A.
    Gasperini, Claudio
    Kappos, Ludwig
    Hartung, Hans-Peter
    Magyari, Melinda
    Oreja-Guevara, Celia
    Trojano, Maria
    Wiendl, Heinz
    Filippi, Massimo
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (11) : 3961 - 3968
  • [9] The Impact of Vaccination Against SARS-CoV-2 Virus on the Outcome of COVID-19 Disease
    AlKhafaji, Dania M.
    Argan, Reem J. Al
    AlBahrani, Salma
    Alwaheed, Abrar J.
    Alqatari, Safi G.
    Al Elq, Abdulmohsen H.
    Albaker, Waleed
    Alwazzeh, Marwan
    AlSulaiman, Amal S.
    AlSulaiman, Reem S.
    Almadan, Hussain M.
    Alhammad, Ali A.
    Almajid, Ali N.
    Hakami, Fatimah H.
    Alanazi, Wafa
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 3477 - 3489
  • [10] The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying Therapies
    Al-Shammri, Suhail
    Chadha, Geeti
    Chattopadhyay, Arpita
    Doi, Suhail
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2023, 32 (02) : 143 - 148
12345